United States · FDA National Drug Code directory

Lansoprazole

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
55111-739_06355b28-9bb0-baea-0f4b-f1e4f7e670b6
Product NDC
55111-739
Form
CAPSULE, DELAYED RELEASE
Composition / generic term
Lansoprazole
Labeler
Dr. Reddy's Laboratories Limited
Marketing category
ANDA
Marketing start / end (source format)
20190819
Source listing expiry
20271231

Source-listed ingredients

  • LANSOPRAZOLE — 15 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 2 BOTTLE in 1 CARTON (55111-739-27) / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE · 55111-739-27
  • 3 BOTTLE in 1 CARTON (55111-739-33) / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE · 55111-739-33
  • 1 BOTTLE in 1 CARTON (55111-739-52) / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE · 55111-739-52

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →